Nippon Shinyaku Co., Ltd. - Product Pipeline Review - 2015

Published: October 2015
No. of Pages: 38
   

Global Markets Direct’s, ‘Nippon Shinyaku Co., Ltd. Product Pipeline Review 2015’, provides an overview of the Nippon Shinyaku Co., Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Nippon Shinyaku Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope


  • The report provides brief overview of Nippon Shinyaku Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Nippon Shinyaku Co., Ltd.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Nippon Shinyaku Co., Ltd.’s pipeline products

Reasons to buy


  • Evaluate Nippon Shinyaku Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Nippon Shinyaku Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Nippon Shinyaku Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Nippon Shinyaku Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Nippon Shinyaku Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
  • Explore the dormant and discontinued projects of Nippon Shinyaku Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Nippon Shinyaku Co., Ltd. - Product Pipeline Review - 2015

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Nippon Shinyaku Co., Ltd. Snapshot 5
Nippon Shinyaku Co., Ltd. Overview 5
Key Information 5
Key Facts 5
Nippon Shinyaku Co., Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
Nippon Shinyaku Co., Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Nippon Shinyaku Co., Ltd. - Pipeline Products Glance 12
Nippon Shinyaku Co., Ltd. - Late Stage Pipeline Products 12
Pre-Registration Products/Combination Treatment Modalities 12
Phase III Products/Combination Treatment Modalities 13
Nippon Shinyaku Co., Ltd. - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Phase I Products/Combination Treatment Modalities 15
Nippon Shinyaku Co., Ltd. - Drug Profiles 16
selexipag 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
prulifloxacin 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
afacifenacin 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
NS-141 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
NS-018 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
NS-065 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
NS-580 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Nippon Shinyaku Co., Ltd. - Pipeline Analysis 25
Nippon Shinyaku Co., Ltd. - Pipeline Products by Target 25
Nippon Shinyaku Co., Ltd. - Pipeline Products by Route of Administration 26
Nippon Shinyaku Co., Ltd. - Pipeline Products by Molecule Type 27
Nippon Shinyaku Co., Ltd. - Pipeline Products by Mechanism of Action 28
Nippon Shinyaku Co., Ltd. - Recent Pipeline Updates 29
Nippon Shinyaku Co., Ltd. - Dormant Projects 31
Nippon Shinyaku Co., Ltd. - Discontinued Pipeline Products 32
Discontinued Pipeline Product Profiles 32
NS-8 32
prulifloxacin 32
selexipag 32
Nippon Shinyaku Co., Ltd. - Company Statement 33
Nippon Shinyaku Co., Ltd. - Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Appendix 37
Methodology 37
Coverage 37
Secondary Research 37
Primary Research 37
Expert Panel Validation 37
Contact Us 37
Disclaimer 38

List of Tables

Nippon Shinyaku Co., Ltd., Key Information 5
Nippon Shinyaku Co., Ltd., Key Facts 5
Nippon Shinyaku Co., Ltd. - Pipeline by Indication, 2015 7
Nippon Shinyaku Co., Ltd. - Pipeline by Stage of Development, 2015 8
Nippon Shinyaku Co., Ltd. - Monotherapy Products in Pipeline, 2015 9
Nippon Shinyaku Co., Ltd. - Partnered Products in Pipeline, 2015 10
Nippon Shinyaku Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2015 11
Nippon Shinyaku Co., Ltd. - Pre-Registration, 2015 12
Nippon Shinyaku Co., Ltd. - Phase III, 2015 13
Nippon Shinyaku Co., Ltd. - Phase II, 2015 14
Nippon Shinyaku Co., Ltd. - Phase I, 2015 15
Nippon Shinyaku Co., Ltd. - Pipeline by Target, 2015 25
Nippon Shinyaku Co., Ltd. - Pipeline by Route of Administration, 2015 26
Nippon Shinyaku Co., Ltd. - Pipeline by Molecule Type, 2015 27
Nippon Shinyaku Co., Ltd. - Pipeline Products by Mechanism of Action, 2015 28
Nippon Shinyaku Co., Ltd. - Recent Pipeline Updates, 2015 29
Nippon Shinyaku Co., Ltd. - Dormant Developmental Projects,2015 31
Nippon Shinyaku Co., Ltd. - Discontinued Pipeline Products, 2015 32
Nippon Shinyaku Co., Ltd., Other Locations 34
Nippon Shinyaku Co., Ltd., Subsidiaries 36

List of Figures

Nippon Shinyaku Co., Ltd. - Pipeline by Top 10 Indication, 2015 7
Nippon Shinyaku Co., Ltd. - Pipeline by Stage of Development, 2015 8
Nippon Shinyaku Co., Ltd. - Monotherapy Products in Pipeline, 2015 9
Nippon Shinyaku Co., Ltd. - Partnered Products in Pipeline, 2015 10
Nippon Shinyaku Co., Ltd. - Pipeline by Top 10 Target, 2015 25
Nippon Shinyaku Co., Ltd. - Pipeline by Top 10 Route of Administration, 2015 26
Nippon Shinyaku Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015 27
Nippon Shinyaku Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015 28

Published By: Global Markets Direct
Product Code: Global Markets Direct13278


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we�ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Pharmaceuticals market as per your needs. Get the best of Pharmaceuticals research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: